人类内源性逆转录病毒K上调与肺动脉高压免疫炎症相关
该研究从肺动脉高压(PAH)肺免疫复合物中鉴定出SAMHD1抗原,并发现其与HERV-K表达升高相关。HERV-K的dUTPase可诱导SAMHD1和促炎细胞因子,增加肺动脉内皮细胞凋亡,并在大鼠中引发肺动脉高压血流动力学和血管改变。
要点
- PAH肺免疫复合物中SAMHD1高表达,定位于内皮细胞、血管周围树突细胞和巨噬细胞。
- HERV-K在PAH肺中表达升高,其dUTPase可诱导单核细胞和内皮细胞产生促炎因子。
- HERV-K dUTPase注射可在大鼠中诱导肺动脉高压样血流动力学和血管改变。
核心结论
- 内源性逆转录病毒HERV-K上调可启动并维持免疫系统激活,并导致与PAH相关的血管改变。
研究设计与样本
- 研究对比了16例遗传性和特发性PAH与12例对照肺组织中的免疫复合物,通过液相色谱串联质谱鉴定抗原,并用ELISA和共聚焦显微镜确认和定位。
- 使用宏基因组测序(n=4)和肺组织mRNA检测(n=10)分析HERV-K表达,并在培养的单核细胞和内皮细胞中进行功能研究。
- 在大鼠(n=8)中每周注射HERV-K dUTPase 3次,评估血流动力学和血管变化。
主要发现
- SAMHD1在16例遗传性和特发性PAH的免疫复合物中高表达,而12例对照肺组织低表达。
- SAMHD1定位于内皮细胞、血管周围树突细胞和巨噬细胞,SAMHD1抗体在三级淋巴组织中普遍存在。
- 宏基因组测序(n=4)显示PAH肺中HERV-K表达增加,HERV-K包膜和dUTPase mRNA在PAH肺中升高(n=10),蛋白定位于巨噬细胞。
- HERV-K dUTPase可诱导循环单核细胞、肺动脉内皮细胞和B细胞中的SAMHD1及促炎细胞因子(如IL-6、IL-1β、TNF-α)。
- HERV-K dUTPase以不依赖IL-6的方式增加肺动脉内皮细胞对凋亡的易感性,并在大鼠中诱导肺动脉高压的血流动力学和血管改变及IL-6升高。
临床怎么用
- HERV-K及其dUTPase可能作为PAH免疫调节治疗的潜在靶点。
- SAMHD1和HERV-K相关抗体或可作为PAH免疫激活的生物标志物。
局限性
- 研究样本量较小(PAH 16例、对照12例、测序n=4、mRNA n=10、大鼠n=8)。
- 机制研究主要在体外细胞和大鼠模型中进行,尚未在人体中验证因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune dysregulation has been linked to occlusive vascular remodeling in pulmonary arterial hypertension (PAH) that is hereditary, idiopathic, or associated with other conditions. Circulating autoantibodies, lung perivascular lymphoid tissue, and elevated cytokines have been related to PAH pathogenesis but without a clear understanding of how these abnormalities are initiated, perpetuated, and connected in the progression of disease. We therefore set out to identify specific target antigens in PAH lung immune complexes as a starting point toward resolving these issues to better inform future application of immunomodulatory therapies. METHODS: Lung immune complexes were isolated and PAH target antigens were identified by liquid chromatography tandem mass spectrometry, confirmed by enzyme-linked immunosorbent assay, and localized by confocal microscopy. One PAH antigen linked to immunity and inflammation was pursued and a link to PAH pathophysiology was investigated by next-generation sequencing, functional studies in cultured monocytes and endothelial cells, and hemodynamic and lung studies in a rat. RESULTS: SAM domain and HD domain-containing protein 1 (SAMHD1), an innate immune factor that suppresses HIV replication, was identified and confirmed as highly expressed in immune complexes from 16 hereditary and idiopathic PAH versus 12 control lungs. Elevated SAMHD1 was localized to endothelial cells, perivascular dendritic cells, and macrophages, and SAMHD1 antibodies were prevalent in tertiary lymphoid tissue. An unbiased screen using metagenomic sequencing related SAMHD1 to increased expression of human endogenous retrovirus K (HERV-K) in PAH versus control lungs (n=4). HERV-K envelope and deoxyuridine triphosphate nucleotidohydrolase mRNAs were elevated in PAH versus control lungs (n=10), and proteins were localized to macrophages. HERV-K deoxyuridine triphosphate nucleotidohydrolase induced SAMHD1 and proinflammatory cytokines (eg, interleukin 6, interleukin 1β, and tumor necrosis factor α) in circulating monocytes, pulmonary arterial endothelial cells, and also activated B cells. Vulnerability of pulmonary arterial endothelial cells (PAEC) to apoptosis was increased by HERV-K deoxyuridine triphosphate nucleotidohydrolase in an interleukin 6-independent manner. Furthermore, 3 weekly injections of HERV-K deoxyuridine triphosphate nucleotidohydrolase induced hemodynamic and vascular changes of pulmonary hypertension in rats (n=8) and elevated interleukin 6. CONCLUSIONS: Our study reveals that upregulation of the endogenous retrovirus HERV-K could both initiate and sustain activation of the immune system and cause vascular changes associated with PAH.
引用
- Saito T, Miyagawa K, Chen SY, et al. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension. Circulation. 2017. PMID: 28935667. doi:10.1161/CIRCULATIONAHA.117.027589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。